Search

everythinglearnresearchcommunity

for

Search:↓

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

New genes and pathways are important for testosterone production and male sexual development.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

The inhibitor affects androgen metabolism but not ovarian function.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The enzyme Dgat1 is essential for healthy hair and skin by controlling retinoid levels.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.